Largest biotech companies in the United States by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 20 biotech companies in the United States ranked by net assets, at NZ$41.3B, ahead of Biogen (NZ$33.2B) and Amgen (NZ$15.7B). Figures as of 20 Nov 2026, 12:36 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Gilead SciencesNZ$41.3B
Median
NZ$2.9B
Combined market value
NZ$1.34T
Countries
1

Market values as of .

United States
All sectors
Biotech
NZD
Clear filters
Largest biotech companies in the United States by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareNZ$41.3BNZ$375.5BNZ$302.73 1.45% down 31% up United States
2BiogenBIIB · Health CareNZ$33.2BNZ$66.4BNZ$449.26 1.70% down 41% up United States
3AmgenAMGN · Health CareNZ$15.7BNZ$431.5BNZ$797.73 1.14% down 30% up United States
4ModernaMRNA · Health CareNZ$15.7BNZ$146.6BNZ$362.36 1.29% up 740% up United States
5Neurocrine BiosciencesNBIX · Health CareNZ$5.9BNZ$28.8BNZ$284.66 3.85% down 10% up United States
6VaxcytePCVX · Health CareNZ$4.9BNZ$16.8BNZ$106.09 0.27% down 22% up United States
7ExelixisEXEL · Health CareNZ$3.9BNZ$29.2BNZ$119.67 3.60% down 55% up United States
8Bio-TechneTECH · Health CareNZ$3.8BNZ$20.8BNZ$132.16 0.07% down 18% up United States
9RepligenRGEN · Health CareNZ$3.8BNZ$19.8BNZ$309.57 1.38% down 5% up United States
10Revolution MedicinesRVMD · Health CareNZ$3BNZ$62.7BNZ$289.83 0.24% down 125% up United States
11Kymera TherapeuticsKYMR · Health CareNZ$2.9BNZ$18.5BNZ$217.04 1.44% down 81% up United States
12Krystal BiotechKRYS · Health CareNZ$2.2BNZ$17BNZ$574.13 0.15% up 49% up United States
13ImmunovantIMVT · Health CareNZ$1.5BNZ$12.2BNZ$59.12 1.96% down 44% up United States
14CG OncologyCGON · Health CareNZ$1.4BNZ$13.3BNZ$148.89 2.38% up 93% up United States
15Twist BioscienceTWST · Health CareNZ$859.8MNZ$13.8BNZ$202.91 4.07% down 291% up United States
16Scholar Rock HoldingSRRK · Health CareNZ$446.3MNZ$11.2BNZ$91.57 4.94% up 25% up United States
17Adaptive BiotechnologiesADPT · Health CareNZ$397.7MNZ$8.3BNZ$50.99 1.44% down 51% up United States
18Kodiak SciencesKOD · Health CareNZ$286.1MNZ$11.6BNZ$177.97 0.09% up 371% up United States
19Halozyme TherapeuticsHALO · Health CareNZ$88.7MNZ$19.3BNZ$169.14 2.88% down 32% up United States
20ImmunityBioIBRX · Health Care-NZ$909.8MNZ$12.7BNZ$11.94 1.94% down 216% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.8179 NZD).

Questions and answers

Which biotech companies in the United States rank first by net assets?

Gilead Sciences (NZ$41.3B), Biogen (NZ$33.2B) and Amgen (NZ$15.7B) are the top three of the 20 biotech companies in the United States ranked by net assets as of 20 Nov 2026, 12:36 UTC.

How many biotech companies in the United States are in this ranking?

20 are ranked by net assets.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by net assets have a combined market value of NZ$1.34T as of 20 Nov 2026, 12:36 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech companies in the United States by net assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.